King-Jones Heidy — insider trades

Stock trades King-Jones Heidy reported on SEC Form 4 at SYRE Spyre Therapeutics, Inc..

• Oct 1, 2026: sold 28,933 shares of SYRE Spyre Therapeutics, Inc. ($2.63M)
• Sep 2, 2026: sold 28,399 shares of SYRE Spyre Therapeutics, Inc. ($2.48M)